Nejad, E. M., Amouzadeh, E., Kashipazha, D., Shamsaei, G., & Cheraghian, B. (2023). The effect of atomoxetine on cognitive function in patients with multiple sclerosis. Current Journal of Neurology, 22(3), 149. https://doi.org/10.18502/cjn.v22i3.13792
Chicago Style (17th ed.) CitationNejad, Ehsan Mohammadian, Effat Amouzadeh, Davood Kashipazha, Gholamreza Shamsaei, and Bahman Cheraghian. "The Effect of Atomoxetine on Cognitive Function in Patients with Multiple Sclerosis." Current Journal of Neurology 22, no. 3 (2023): 149. https://doi.org/10.18502/cjn.v22i3.13792.
MLA (9th ed.) CitationNejad, Ehsan Mohammadian, et al. "The Effect of Atomoxetine on Cognitive Function in Patients with Multiple Sclerosis." Current Journal of Neurology, vol. 22, no. 3, 2023, p. 149, https://doi.org/10.18502/cjn.v22i3.13792.